Latest Breast Updates from ASCO 2009

posted Jun 22 2009
We would like to thank Dr Sunil Verma for the latest ASCO Conference updates

Ribbon-1: Randomized, Double-blind, Placebo, Phase III Trial of First Line Chemo With or Without Bevacizumab for MBC

Efficacy of BSI-201, a PARP-Inhibitor in combination with Gemcitabine/Carboplatin in Triple Negative Breast Cancer: Randomized Phase II trial